A carregar...
MEK1/2 inhibitors sensitize Bcr/Abl(+) human leukemia cells to the dual Abl/Src inhibitor BMS-354/825
Interactions between MEK1/2 inhibitors and the dual Abl/Src kinase inhibitor dasatinib (BMS-354825) were examined in chronic myeloid leukemia (CML) cell lines and primary specimens. Cotreatment of K562 or LAMA cells with subtoxic or marginally toxic concentrations of PD184352 (or U0126) and dasatini...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1874569/ https://ncbi.nlm.nih.gov/pubmed/17218385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-09-045039 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|